Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 71 results for "Myelodysplastic Syndromes (MDS)".

Thumbnail for Artificial Intelligence in the Diagnosis of Severe Aplastic Anemia: A Systematic Review of Emerging Diagnostic Models

MDS - 098

Artificial Intelligence in the Diagnosis of Severe Aplastic Anemia: A Systematic Review of Emerging Diagnostic Models

Eman M Nagiub

Poster Presenter: Eman M Nagiub

Thumbnail for Rising Mortality and Persistent Disparities in Hematologic Malignancies and Aplastic Anemia Among U.S. Adults: A Population-Based Analysis, 1999-2025

MDS - 1007

Rising Mortality and Persistent Disparities in Hematologic Malignancies and Aplastic Anemia Among U.S. Adults: A Population-Based Analysis, 1999-2025

Muhammad Jawad

Poster Presenter: Muhammad Jawad

Thumbnail for Cooperative Effects of U2AF1-S34 and BCOR Mutations in Myeloid Neoplasms

Previous 1 2 3 4...8 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MDS - 1034

Cooperative Effects of U2AF1-S34 and BCOR Mutations in Myeloid Neoplasms

Akram Abushamma

Poster Presenter: Akram Abushamma

Thumbnail for Spliceosome-Targeting Therapies in SF3B1-Mutated Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis of Clinical Efficacy and Safety

MDS - 1049

Spliceosome-Targeting Therapies in SF3B1-Mutated Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis of Clinical Efficacy and Safety

Ashil Mulllath

Poster Presenter: Ashil Mulllath

Thumbnail for A Phase 2 Open-Label Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's-Choice Thrombopoietin Receptor Agonist in Patients With Primary Immune Thrombocytopenia: VAY2EXPLORE Study Design

MDS - 1074

A Phase 2 Open-Label Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's-Choice Thrombopoietin Receptor Agonist in Patients With Primary Immune Thrombocytopenia: VAY2EXPLORE Study Design

Mary Lisha Paul

Poster Presenter: Mary Lisha Paul

$Thumbnail for Clinical Efficacy of the Novel Oral NEK7 Inflammasome Inhibitor Ofirnoflast in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndromes With High-Risk Mutational Profiles: A Case Series$

MDS - 1093

Clinical Efficacy of the Novel Oral NEK7 Inflammasome Inhibitor Ofirnoflast in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndromes With High-Risk Mutational Profiles: A Case Series

Jeremiah Bearss

Poster Presenter: Jeremiah Bearss

Thumbnail for Elevated Interleukin 1ί and Reduced Interleukin 5 in Low-Risk Myelodysplastic Syndromes with Grade 2 or Higher Bone Marrow Fibrosis

MDS - 1103

Elevated Interleukin 1ί and Reduced Interleukin 5 in Low-Risk Myelodysplastic Syndromes with Grade 2 or Higher Bone Marrow Fibrosis

Maria Stella Martino

Poster Presenter: Maria Stella Martino

Thumbnail for “STAG2-Mutated MDS: Not Only Loss-of-Function?"

MDS - 1116

“STAG2-Mutated MDS: Not Only Loss-of-Function?"

Gloria Andreossi

Poster Presenter: Gloria Andreossi

Thumbnail for Mortality Trends Due to Myelodysplastic Syndrome-Associated Anemia in the United States(1999-2024): A 25- Year Retrospective Analysis With Future Projections to 2035

MDS - 1117

Mortality Trends Due to Myelodysplastic Syndrome-Associated Anemia in the United States(1999-2024): A 25- Year Retrospective Analysis With Future Projections to 2035

Pakeeza Saif

Poster Presenter: Pakeeza Saif

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors